HeyJaredThomas Niel
- Indexed articles, last 90 days
- 53
- Latest publication
- Sep 22, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 4, 2026
Latest articles
Should You Buy Moderna Stock? Why Many Wall Street Analysts Say "No." (opens the original)
Read excerpt
Moderna (NASDAQ: MRNA) has remained one of the market's hottest biotech stocks. Even as the vaccine maker's shares remain off their 52-week high, hit by news of a breakthrough in using its mRNA technology to create marketable drugs for other diseases and ailments, not just for COVID-19, at around $157 per share, they're still up over sixfold over the past 12 months. Yet while Moderna may still be sitting pretty right now, analysts remain skeptical whether the stock can hold on to its latest spat
Move Over, Tesla: This Robotics Stock Already Has Paying Customers (opens the original)
Read excerpt
Tesla (NASDAQ: TSLA) hasn't released its Optimus humanoid robot commercially, but the hype surrounding it remains high. In fact, recent news about supplier audits in China suggests that a massive ramp-up in Optimus production could begin later this year. While Tesla's Optimus catalyst gets closer, consider that there's already a company in the robotics field generating material revenue from customers. Maybe Tesla shouldn't be the sole wager among robotics stocks. Missed Nvidia in 2009? This Rare
History Says This Is the Amount of Yearly Dividend Income a $10,000 Investment in Coca-Cola Stock Could Generate by 2036 (opens the original)
Read excerpt
From everyday investors to Warren Buffett's holding company, Berkshire Hathaway, many have made Coca-Cola (NYSE: KO) a core portfolio position, largely due to its long track record of dividend growth. Coca-Cola is one of the Dividend Kings, or stocks with at least 50 years of consecutive annual dividend increases. Expecting this trend to continue, how much could a $10,000 position in Coca-Cola, entered today, yield you in 2036? Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009,
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant (opens the original)
Read excerpt
When it comes to long-term success with dividend investing, you need to focus on criteria beyond just yield. While some high yield dividend stocks can be worth the risk, there are plenty that are trading at a high yield for a good reason. That is, either they are at risk of cutting or suspending their payouts, and/or other risks may lead to stock price declines that outweigh the returns generated by their large payouts. So, instead of focusing on yield alone, consider criteria such as dividend c
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better? (opens the original)
Read excerpt
As seen in Canopy Growth's (NASDAQ: CGC) latest quarterly earnings release, a turnaround remains in motion. In its fiscal 2027's first quarter, ended June 30, 2026, the Canada-based cannabis company reported net revenue of $81.2 million CAD ($58.6 million), a 13% increase compared to the prior year's quarter. More importantly, the company reported higher gross margins, a 68% decrease in net losses, and 59% drop in adjusted EBITDA losses. While not yet a perfect situation, things are clearly impr
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.